Y-R. Shi

机构：Hunan Cancer Hospital

发表论文 1 篇 · 总被引 12 次 · h-index 1

代表论文

• 860MO MRG003: A novel EGFR-targeted antibody-drug conjugant (ADC) for recurrent/metastatic nasopharyngeal carcinoma (2023 · Annals of Oncology · 被引 12)